Market Indices
Sector Heatmap
MSLE — Satellos Bioscience Inc. Common Stock
NasdaqSatellos Bioscience Inc. Common Stock
- O
- 8.08
- H
- 8.38
- L
- 7.54
- V
- 47.52K
MSLE — Latest News & Headlines
9 StoriesA possible treatment for muscle diseases gains U.S. patent protection through 2044. - Stock Titan
A possible treatment for muscle diseases gains U.S. patent protection through 2044. Stock Titan
Satellos Bioscience Inc. (NASDAQ:MSLE) Stock Rated "Moderate Buy" by Wall Street Brokerages - MarketBeat
Satellos Bioscience Inc. (NASDAQ:MSLE) Stock Rated "Moderate Buy" by Wall Street Brokerages MarketBeat
Satellos stock jumps after FDA clears FSHD trial for forazapadin - Yahoo Finance
Satellos stock jumps after FDA clears FSHD trial for forazapadin Yahoo Finance
Satellos Bioscience Inc. Common Stock (NASDAQ: MSLE) Stock Price, News & Analysis - kalkine.ca
Satellos Bioscience Inc. Common Stock (NASDAQ: MSLE) Stock Price, News & Analysis kalkine.ca
MSLE: Satellos Bioscience Inc. - Comparative Chart - Zacks Investment Research
MSLE: Satellos Bioscience Inc. - Comparative Chart Zacks Investment Research
A U.S. patent covers more than forazapadin for Satellos Bioscience (MSLE). - Stock Titan
A U.S. patent covers more than forazapadin for Satellos Bioscience (MSLE). Stock Titan
Jack In The Box Brings Back Iconic Burger For 75th Anniversary, But It Was Just Another Hot Mess For Its Stock As Earnings Loom - Stocktwits
Jack In The Box Brings Back Iconic Burger For 75th Anniversary, But It Was Just Another Hot Mess For Its Stock As Earnings Loom Stocktwits
Enrollment surpassed its target in under nine months. Satellos (MSLE) plans BASECAMP results. - Stock Titan
Enrollment surpassed its target in under nine months. Satellos (MSLE) plans BASECAMP results. Stock Titan
FDA clears a Satellos (MSLE) drug study for a disease affecting an estimated 800,000 people worldwide. - Stock Titan
FDA clears a Satellos (MSLE) drug study for a disease affecting an estimated 800,000 people worldwide. Stock Titan